Dr. Bethany Crouse is a Research Project Manager at HealthPartners Institute. Before joining the Institute, Dr. Crouse received her PhD in Pharmacology from the University of Minnesota in 2022, focusing on development of vaccines for opioid use disorders. Prior to this, she received a BS in Biochemistry from the University of Montana.

At the Institute, Dr. Crouse primarily supports clinical studies through the Neuroscience Research Center. She supports a portfolio of projects related to development of intranasal medications to treat neurological diseases, including Parkinson’s disease (PD), Alzheimer’s disease (AD), and traumatic brain injury. Other projects include topics such as clinical decision support, support for AD caregivers, and testing of devices for diagnosis and treatment of AD and PD.

Conducting Institute research since: 2022

Education and Training
PhD, Pharmacology, University of Minnesota
BS, Biochemistry, University of Minnesota

Research Interests include:
Neurological diseases
Intranasal drug delivery
Drug/device studies
Vaccines

Current research activities and funding include:

• A clinical decision support tool to increase detection of cognitive impairment in primary care
• Intranasal insulin as a treatment for traumatic brain injury
• Pharmacokinetics of insulin after intranasal administration
• Intranasal insulin as a treatment for Parkinson’s Disease
• Pharmacokinetics of deferoxamine after intranasal administration
• Care Ecosystem: a program to support caregivers of people with dementia
• A continuous wearable monitor for the detection and release of freezing of gate in people with Parkinson’s Disease
• An insole device to monitor cognitive decline in individuals at risk for Alzheimer’s Disease